decentralized trials

Clinical trial management systems market expands from $2.25B in 2025 to $4.2B by 2030, driven by cloud adoption, AI integration, and decentralized trial models.

AI clinical trial feasibility market expands from $0.83B (2025) to $2.76B by 2030 at 27.3% CAGR, driven by precision medicine and decentralized trials.

Clinical trial data visualization market projected to grow from $0.89B (2025) to $1.82B (2030) at 15.4% CAGR, driven by AI adoption and decentralized trials.

Mental health clinical trials market projected to grow 51% from $3.23B (2025) to $4.89B (2030) at 8.6% CAGR, driven by digital innovation and Asia-Pacific expansion.

Clinical trial software market projected to grow from $1.32B in 2025 to $2.53B by 2030, driven by AI adoption and virtual trials.

Clinical trials tech market projected to grow 59% from $51.15B (2025) to $81.46B (2030) at 9.8% CAGR, driven by AI, decentralized models, and digital transformation.

Clinical trial software market projected to nearly triple to $34.15B by 2035, driven by pharmaceutical industry's digital transformation and increased adoption of AI-enabled solutions.